Clinical Trials
3 trialsNCT00436566 2022-08-05
Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery
Mayo Clinic
Phase 2 Completed
NCT00875238 2018-02-19
PACE in BC
Vanderbilt University Medical Center
Completed
NCT00968682 2014-12-31
CADY Study ICORG 08-01
Cancer Trials Ireland
Completed